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Abstract
Background: Although the R230C-ATP-binding cassette A1 (ABCA1) variant has been consistently associated with
HDL-C levels, its association with diabetes and other metabolic parameters is unclear. Estrogen and dietary factors
are known to regulate ABCA1 expression in different tissues. Thus, we aimed to explore whether gender, menopausal
status and macronutrient proportions of diet modulate the effect of this variant on various metabolic parameters.
Methods: One thousand five hundred ninety-eight controls from the GEA study were included (787 men, 363
premenopausal women and 448 menopausal women), previously assessed for anthropometric and biochemical
measurements and visceral to subcutaneous abdominal fat (VAT/SAT) ratio on computed tomography. Taqman
assays were performed for genotyping. Diet macronutrient proportions were assessed using a food frequency
questionnaire validated for the Mexican population. Multivariate regression models were constructed to assess
the interaction between the proportion of dietary macronutrients and the R230C polymorphism on metabolic
parameters.
Results: All significant interactions were observed in premenopausal women. Those carrying the risk allele and
consuming higher carbohydrate/lower fat diets showed an unfavorable metabolic pattern [lower HDL-C and
adiponectin levels, higher VAT/SAT ratio, homeostasis model assessment for insulin resistance (HOMA-IR) and
higher gamma-glutamyl transpeptidase (GGT) and alkaline phosphatase (ALP) levels]. Conversely, premenopausal
women carrying the risk allele and consuming lower carbohydrate/higher fat diets showed a more favorable
metabolic pattern (higher HDL-C and adiponectin levels, and lower VAT/SAT ratio, HOMA-IR, GGT and ALP levels).
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Conclusion: This is the first study reporting a gender-specific interaction between ABCA1/R230C variant and dietary
carbohydrate and fat percentages affecting VAT/SAT ratio, GGT, ALP, adiponectin levels and HOMA index. Our study
confirmed the previously reported gender-specific ABCA1-diet interaction affecting HDL-C levels observed in an
independent study. Our results show how gene-environment interactions may help further understand how certain
gene variants confer metabolic risk, and may provide information useful to design diet intervention studies.
Keywords: ABCA1, R230C, Gene-diet interaction, Insulin resistance, Adiponectin, Visceral to subcutaneous abdominal fat
ratio, GGT, HDL-C
Background
The ATP-binding cassette A-1 protein (ABCA1) is es-
sential for the transport of lipids across plasma mem-
branes and cholesterol homeostasis, is known to have
various functions in distinct tissues and plays an essen-
tial role in metabolism [1]. ABCA1 is crucial for high-
density lipoprotein cholesterol (HDL-C) biogenesis in
the liver and intestine [2–4] and is known to regulate in-
sulin secretion in pancreatic β–cells through the modu-
lation of insulin granule exocytosis [5, 6]. Moreover,
hepatic ABCA1 was found to improve glucose tolerance
by enhancing β-cell function through both HDL produc-
tion and interaction with β–cell ABCA1 [7], while
adipocyte-specific ABCA1 was found to prevent fat stor-
age, and to play a role in adipocyte lipid metabolism,
body weight and whole-body glucose homeostasis [8, 9].
The ABCA1 gene is located at 9q31.1, spans 149 kb,
comprises 50 exons and is highly polymorphic. Observa-
tions from genetic association studies are in agreement
with the role of ABCA1 in HDL-C formation, as several
single nucleotide variants (SNVs) have been associated
with HDL-C plasma levels in many studies, although
their overall contribution to HDL-C levels is low [10–15].
In comparison, few studies have reported associations of
ABCA1 gene variants with other metabolic traits such as
type 2 diabetes (T2D) [16–20], body mass index (BMI)
[15], or body fat distribution in women [21, 22]. Particu-
larly in the case of T2D, associations with ABCA1 variants
have been inconsistent [23, 24]. Among the many possible
explanations for these inconsistencies are the possibility of
spurious associations due to population stratification, dif-
ferences in study design, gender bias and dietary factors
known to affect ABCA1 expression.
Gender-related metabolic differences are well known.
ABCA1 is one of the 1249 sex-biased genes found in
liver, expressed at significantly higher levels in females
[25]. Some of these gender-related metabolic differences,
such as higher HDL-C levels in premenopausal women,
can be explained by the effect of estrogen [26, 27]. Both
in the murine model and in humans, estrogen has been
found to increase ABCA1 expression in different tissues
[28, 29]. Moreover, certain dietary components have
been found to regulate ABCA1 expression: different
ABCA1 transcripts were upregulated by a high fat diet
in mice [30]; high glucose, linoleic acid and omega-6 un-
saturated fatty acid suppressed ABCA1 expression while
saturated fatty palmitic acid increased ABCA1 expres-
sion in primary human monocyte-derived macrophages
[31]; unsaturated fatty acids decreased ABCA1 protein
levels by promoting its degradation in HepG2 and hu-
man small intestine epithelial cells [32, 33]; ABCA1 hep-
atic levels were increased in mice fed a high fat diet,
while mulberry leaf and fruit extract treatment counter-
acted this high fat-induced ABCA1 expression [34]; and
black soybean supplementation significantly increased
hepatic ABCA1 mRNA levels in mice with diet-induced
non-alcoholic fatty liver disease (NAFLD) [35]. Although
evidence of dietary factors affecting ABCA1 expression
is abundant, there are relatively few studies reporting of
ABCA1 genetic variants with dietary components. Sig-
nificant interactions of ABCA1 gene variants with diet-
ary macronutrients affecting plasma lipid levels have
been reported in the Inuit population [36], in healthy
young Chinese individuals [37] and in Mexican premen-
opausal women [38], and two diet intervention studies
reported significantly different responses in BMI, HDL-C
and serum adiponectin levels in individuals bearing the
ABCA1/R230C variant [39, 40].
The ABCA1/R230C variant (rs9282541) was found to
be private to the Americas and strongly associated with
low HDL-C in Mexican mestizos and Native American
populations [15, 41]. This allele is of particular interest,
because it is frequent in the Mexican mestizo population
(10 %) and the sole presence of the C risk allele explains
almost 4 % of plasma HDL-C concentration variation,
which is higher than all HDL-C variation associated with
a single nucleotide polymorphism identified through
genome-wide association studies in European and Asian
populations [42]. Although the ABCA1/R230C variant
has been consistently associated with HDL-C levels, its
association with diabetes and other metabolic parame-
ters is unclear. Thus, we aimed to explore whether gen-
der, menopausal status and dietary macronutrient
composition modulate the effect of the ABCA1/R230C
variant on plasma lipid levels and other cardiometabolic
risk parameters.
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Methods
The study included a total of 1598 controls recruited
from the GEA Study, which was designed to investigate
genetic factors associated with premature coronary ar-
tery disease, subclinical atherosclerosis and other coron-
ary risk factors in the Mexican population [21]. All
participants provided written informed consent, and the
study was approved by the Ethics Committee of the
Instituto Nacional de Cardiología “Ignacio Chávez”
(INCICH) and the Ethics Committee of the Instituto
Nacional de Medicina Genómica (INMEGEN). All par-
ticipants answered standardized and validated question-
naires to obtain information on family and medical
history, menopausal status, alcohol and tobacco con-
sumption, dietary habits and physical activity [43, 44].
Menopausal status was defined as absence of menses for
more than 12 months on interrogation. Anthropometric
and metabolic measurements included BMI, HDL-C,
low density lipoprotein cholesterol (LDL-C), total chol-
esterol (TC), triglyceride (TG), aspartate transaminase
(AST), alanine transaminase (ALT), alkaline phosphatase
(ALP), gamma-glutamyl transpeptidase (GGT), adipo-
nectin serum levels, homeostasis model for assessment
of insulin resistance (HOMA-IR)], and visceral abdominal
fat to subcutaneous abdominal fat (VAT/SAT) ratio on
computed tomography scans were measured as previously
described [21, 45].
Dietary assessment
Dietary assessment was performed using a Food Fre-
quency Questionnaire (FFQ) previously validated for the
Mexican population by the Instituto Nacional de Salud
Pública, using a 116-item semiquantitative FFQ designed
to estimate the usual dietary intake over the previous
12-month period [44]. Specifically, this questionnaire
was designed to classify individuals by the relative intake
of 20 nutrients from 82 foods of the Mexican diet. The
FFQ collects specific information on the consumption of
fats, carbohydrates, proteins and other nutrients. The
validity and reproducibility of this questionnaire to as-
sess dietary intake of a number of nutrients has been
assessed previously in this population [44]. Energy in-
take, and the proportion of macronutrients consumed
daily were estimated using the system evaluation of
nutritional habits and food intake (SNUT) [46].
Genetic analysis
Genomic DNA was extracted and purified from white
blood cells using the salting-out procedure [47]. The
ABCA1/R230C variant (rs9282541) was genotyped using
TaqMan assay number C_11720861_10, following the
manufacturer’s recommendations in an ABI Prism
7900HT sequence detection system (Applied Biosys-
tems). Genotyping call exceeded 95 % and no discordant
genotypes were observed in 184 duplicate samples. Pre-
viously sequenced samples of all genotypes (RR, RC and
CC) were used as positive controls.
Statistical analyses
Statistical calculations and graphs were made using R
[48]. For all calculations, anthropometric and metabolic
variables (except age, waist circumference and LDL-C)
were log-transformed due to skewed distribution. Geno-
type frequencies did not deviate from Hardy-Weinberg
equilibrium (P = 0.57). Because of the reduced number
of CC homozygous individuals, RC and CC genotypes
were analyzed as a single group using a dominant model.
Pearson’s correlations were calculated to study the linear
relationship between macronutrient proportions and an-
thropometric and metabolic variables, stratified by gen-
der, menopausal status and ABCA1/R230C genotype. To
address multiple testing for the correlation analysis, we
calculated Bonferroni’s correction using Simple Inter-
active Statistical Analyses Software [49] assuming 12
measurements and an average pairwise correlation of
0.21; P-value below 0.007 was considered significant. All
variables that showed no significant correlation with
macronutrients for RR genotypes, but a significant cor-
relation with at least one macronutrient for RC/CC
genotypes, were tested for gene-diet interactions. Multi-
variate regression models were used to assess the inter-
action between the proportion of dietary components
and the R230C variant on the dependent variables and
to assess their predictive effect, adjusting for age, BMI
and alcohol consumption as appropriate. The study
power to detect interactions between the ABCA1/R230C
variant and dietary fat percentage affecting HDL-C,
HOMA-IR, VAT/SAT ratio, adiponectin, ALP and GGT
levels in premenopausal women was calculated using
QUANTO software version 1.2.4 [50], assuming a dom-
inant model with a minor allele (T) frequency of 0.11
and parameters estimated from the study population.
Statistical power ranged between 60 % and 90 % for all
variables except for HOMA-IR, which only reached 36 %.
Results
Anthropometric and biochemical characteristics of the
population stratified according to gender and meno-
pausal status are shown in Additional file 1: Tables S1
and S2. All correlations between macronutrient percent-
ages and metabolic parameters stratified by gender,
menopausal status and ABCA1/R230C genotypes are
depicted as a correlation matrix in Fig. 1. Overall, corre-
lations between macronutrient percentages and various
metabolic parameters were of greater magnitude in
women bearing RC and CC genotypes, particularly in
premenopausal women. Interestingly, in the latter group,
five metabolic parameters (HDL-C, HOMA-IR, VAT/
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SAT ratio, Adiponectin, and ALP) showed no significant
correlation with macronutrients for RR genotypes, but
significant correlations with at least one macronutrient
for RC/CC genotypes after Bonferroni’s correction
(Additional file 1: Table S3). The correlation between
dietary fat percentage and GGT levels in RC/CC premen-
opausal women showed borderline significance (P = 0.008)
and was also tested for interactions. Median values for
these six metabolic parameters according to ABCA1/
R230C genotypes in the entire study population and in
premenopausal women are described in Additional file 1:
Table S4. Additional file 1: Tables S5 and S6 show median
values for these metabolic parameters according to
genotype and stratified by dietary carbohydrate and fat
percentage tertiles.
HDL-C and adiponectin serum levels showed negative
and significant correlations with dietary carbohydrate
percentage and positive significant correlations with fat
percentage in premenopausal women with RC and CC
genotypes, but not in women with wild-type (RR) geno-
types (Additional file 1: Table S3). Both carbohydrate
and fat ABCA1/R230C interactions affecting HDL-C and
adiponectin serum levels showed statistical significance
(Pinteraction <0.04) (Figs. 2a and 3a).
Correlations between dietary macronutrients and
HOMA-IR, VAT/SAT ratio, ALP and GGT showed simi-
lar patterns in premenopausal women. All these
parameters showed positive and significant correlations
with dietary carbohydrate percentage and negative sig-
nificant correlations with fat percentage in premeno-
pausal women with RC/CC genotypes, but not in
women with wild-type (RR) genotypes. Interactions be-
tween ABCA1/R230C and dietary carbohydrate and fat
affecting VAT/SAT ratio, ALP and GGT levels were sta-
tistically significant (P < 0.03) (Figs. 2c, 3b and 3c); these
interactions showed a tendency to significance for
HOMA-IR (P = 0.075 and P = 0.058, respectively) (Fig. 2b).
Interestingly, TG levels showed a positive and signifi-
cant correlation with dietary carbohydrate percentage
(P < 0.002), and a negative significant correlation with
dietary fat percentage (P < 0.001) in premenopausal
women with RC/CC genotypes, however gene-diet in-
teractions lacked statistical significance.
Dietary protein percentage correlated negatively with
ALP levels in premenopausal women with RC/CC geno-
types, with borderline significance (P = 0.008). This inter-
action was statistically significant (Pinteraction = 0.016).
Discussion
We present here evidence suggesting that dietary macro-
nutrient proportions modulate the effect of the func-
tional ABCA1/R230C gene variant on several metabolic
parameters in premenopausal women. Although the total
number of premenopausal women was small (n = 363),
Fig. 1 Correlations between macronutrient percentages and metabolic parameters stratified by gender, menopausal status and ABCA1/R230C genotypes.
Legend: The correlation matrix depicts positive correlations in red and negative correlations in blue. The color scale indicates estimated
Pearson’s correlation coefficient values. Statistical significance of each correlation is proportional to the size of the circle
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several gene-diet interactions became evident and signifi-
cant only in this group. All interactions indicate a meta-
bolically unfavorable pattern in premenopausal women
carrying the risk allele consuming higher carbohydrate
and lower fat diets (lower HDL-C and adiponectin levels,
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Fig. 2 ABCA1/R230C-Dietary Macronutrient Interactions Affecting HDL-C Levels, HOMA-IR and VAT/SAT Ratio in Premenopausal Women. Legend:
Predicted values for: a HDL-C serum levels, b HOMA-IR and c VAT/SAT ratio in premenopausal women according to the percentage of dietary
carbohydrate and fat intake, stratified by ABCA1/R230C genotypes under a dominant model (RR = wildtype homozygotes and RC/CC = risk allele
heterozygotes and homozygotes)
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ALP levels); and a more favorable metabolic pattern in
premenopausal women carrying the risk allele with higher
fat and lower carbohydrate diets (higher HDL-C and
adiponectin levels, and lower VAT/SAT ratio, HOMA-IR,
GGT and ALP levels). Gender differences in carbohydrate
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Fig. 3 ABCA1/R230C-Dietary Macronutrient Interactions Affecting Adiponectin, ALP and GGT Levels in Premenopausal Women. Legend: Predicted
values for: a serum adiponectin, b ALP and c GGT levels in premenopausal women according to the percentage of dietary carbohydrate and fat
intake, stratified by ABCA1/R230C genotypes under a dominant model (RR = wildtype homozygotes and RC/CC = risk allele heterozygotes
and homozygotes)
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differences in metabolic changes in response to diet have
been previously published [53–57], mostly evident in
women of reproductive age. Although the molecular
mechanisms for these differences are not fully understood,
evidence both in humans and animal models has shown
that the effects of estrogen on genes involved in lipid me-
tabolism play an important role [25–29]. In the GEA con-
trol group, ABCA1/R230C was significantly associated
with HDL-C levels [21], but not with any other metabolic
variable. Apparently, the presence of other factors (estro-
gen levels, low dietary fat, and high dietary carbohydrate)
is required for this variant to exert an effect on the other
metabolic parameters.
ABCA1 and serum lipid levels
Many association studies support the role of ABCA1
gene variation in plasma lipid levels. The vast majority
of these studies analyze the role of ABCA1 polymorphisms
on plasma HDL-C levels [10–15]. ABCA1-mediated chol-
esterol efflux being the first step in HDL-C particle forma-
tion likely explains the consistency of the associations of
ABCA1 gene variation with HDL-C levels among different
populations. The well-known inverse correlation between
dietary carbohydrate intake and HDL-C levels [58, 59] was
also observed in control individuals from the GEA study
regardless of gender or genotype. However, in agreement
with the report of Romero-Hidalgo et al. in an independ-
ent Mexican population [38], this inverse correlation was
significantly higher in premenopausal women bearing the
ABCA1/R230C allele (Pinteraction = 0.04). Also in agreement
with this observation, hyperlipidemic R230C allele carriers
showed a better HDL-C serum concentration response
when fed a low-saturated fat diet supplemented with 25 g
soy protein and 15 g soluble fiber, and this response was
more evident in women [39], although the total propor-
tion of macronutrients of this diet was not indicated.
Thus, three independent studies, two based on food fre-
quency questionnaires and one diet intervention study,
confirm a gender-specific ABCA1/R230C-diet interaction
affecting HDL-C serum levels.
ABCA1 gene variants have failed to show significant
associations with triglyceride levels in almost all genetic
association studies analyzing serum lipid levels. To our
knowledge, the R230C variant was significantly associ-
ated with lower TG and total cholesterol levels in
Mayans and Pimas from the United States in only one
study [41], and the authors suggested that other genetic
or environmental factors may play a role on the effect of
ABCA1 on these and other metabolic traits. Interest-
ingly, in the present study although the positive correl-
ation between dietary carbohydrate intake and TG in
premenopausal women was higher for RC/CC genotypes
(r = 0.366; P = 0.002) than for RR genotypes (r = 0.132;
P = 0.031), and the inverse correlation between dietary
fat percentage and TG levels was greater in premenopausal
women with RC/CC genotypes (r = -0.384; P = 0.001) than
in those with RR genotypes (r = -0.122; P = 0.046), these in-
teractions lacked statistical significance. A larger study
using food frequency questionnaires reported that high sat-
urated fat intake was associated with higher triacylglycerol
serum levels in Inuit individuals bearing the CC genotype
of ABCA1/R219K (rs2230806), with no gender effect re-
ported [36]. Because ABCA1/230C allele is less frequent
than the ABCA1/219K allele, a greater sample size may be
necessary to uncover a possible R230C-macronutrient
interaction affecting TG levels.
ABCA1, insulin resistance, VAT/SAT ratio and adiponectin
levels
Although several lines of evidence both in human stud-
ies and animal models indicate that ABCA1 plays a role
in insulin secretion and insulin resistance, the role of
ABCA1 gene variation in T2D susceptibility and insulin
resistance is not fully understood. T2D is not a feature
of Tangier disease, which is caused by recessive loss of
function ABCA1 mutations. However, while ABCA1
knockout mice do not develop T2D, pancreatic beta-cell
specific ABCA1 knockout mice (Abca1-P/-P) showed a
gene-dose dependent and age-related accumulation of
cellular cholesterol in β-cells, marked reduction in insu-
lin secretion in vivo and progressive impairment in
glucose tolerance that was independent of islet develop-
ment or β-cell mass [5], and disruption of insulin
granule exocytosis [6]. Adipocyte specific knockout
mice (Abca1-ad/-ad) also showed impaired glucose tol-
erance, lower insulin sensitivity and decreased insulin
secretion [9].
There are few studies analyzing β-cell function and in-
sulin sensitivity in human heterozygotes for loss-of-
function ABCA1 mutations, with inconsistent results. In
agreement with the mouse model, a small study showed
that 15 individuals with loss-of function ABCA1 muta-
tions showed decreased insulin secretion, mild hypergly-
cemia but no difference in insulin response to an oral
glucose challenge measured by hyperglycemic clamp
[60]. Because none of these ABCA1 mutation carriers
had diabetes, the authors suggested that carriership is a
relatively mild islet susceptibility factor for diabetes by
itself. In contrast, in a recent study including only young
adults, 3 homozygotes and nine heterozygotes for
ABCA1 mutations exhibited enhanced oral glucose toler-
ance and increased β-cell secretory capacity as compared
to control subjects suggesting a gene dose effect, with
no differences in insulin sensitivity [61]. To explain dis-
crepancies with previous studies, the authors suggested
that age and systemic cholesterol availability might influ-
ence the effect of ABCA1 mutations on insulin secretion.
The largest study of loss-of-function mutations included
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94 ABCA1 heterozygotes from the Copenhagen City
Heart Study and the Copenhagen General Population
Study. The authors reported no association with in-
creased risk of T2D in the general population, suggesting
that ABCA1 dysfunction may impact β-cell function, but
is not enough to cause diabetes [24].
It is noteworthy that ABCA1 has never been identified
as a diabetes-associated gene in genome-wide associ-
ation studies GWAS [62–64]. Associations of ABCA1
with T2D have only been observed in a small number of
candidate gene case–control studies, in Japanese, Mexican
and Turkish populations [16–20]. The ABCA1/R230C
variant was associated with early-onset T2D in two in-
dependent small cohorts of the Mexican population
[20], was only marginally associated with T2D in
Pimas (P = 0.06) [41], and was not associated T2D in a
case–control study of the Colombian population [23].
Possible explanations for these inconsistencies include
differences in study design, gender bias, mean age,
population stratification, genetic background, the ef-
fect of plasma lipids, and gene-environment interac-
tions, which should be pointed out as possible
confounding factors for ABCA1 association studies. In
the present study, it was not possible to directly assess
R230C-diet interactions affecting T2D susceptibility
because of the low number of premenopausal women
with T2D (n = 29). However, interactions affecting
T2D-associated metabolic risk parameters (HOMA-IR,
VAT/SAT ratio and adiponectin levels) showed the same
unfavorable pattern in premenopausal women bearing
R230C genotypes with high dietary carbohydrate intake
(Figs. 2b, 2c and 3a). To our knowledge, no single ABCA1
polymorphism has been associated with HOMA-IR or
other measures of insulin resistance. The complexity of
the process of insulin sensitivity suggests that ABCA1
function is probably only one of many factors affecting
glucose uptake by peripheral cells. Although the ABCA1/
R230C diet interactions affecting HOMA-IR observed
here had marginal significance (Pinteraction = 0.058 and
0.075 for dietary fat and carbohydrate intake respectively),
our data suggest that gender and diet are factors that
added to ABCA1 function participate in the complex
process of insulin resistance, and deserve further study.
Circulating adiponectin levels are highly heritable [65]
and are inversely associated with insulin resistance and
T2D [66, 67]. Although the regulation of serum adipo-
nectin levels is complex, experimental evidence suggests
there is a link between ABCA1 and adiponectin. Adipo-
nectin has been found to upregulate ABCA1 expression
in macrophages [68, 69] and to play a role in ABCA1
regulation in hepatocytes [70], while the adipocytes of
Abca1(ad-/ad-) mice were found to have decreased adipo-
nectin expression [9]. Moreover, although ABCA1 has
not been found to be associated with this trait in GWAS
or candidate gene association studies, a dietary interven-
tion study including nopal, chia seed, soy protein and
oat reported that individuals with metabolic syndrome
bearing the ABCA1/R230C variant responded with a
greater decrease in body weight and a sharper increase
in serum adiponectin concentrations [40]. Thus, the sig-
nificant interactions between the ABCA1/R230C variant
and dietary fat/carbohydrate percentages observed in
premenopausal women from the GEA study support this
link between ABCA1 and serum adiponectin levels.
Similarly, increased VAT/SAT ratio is associated with in-
creased metabolic risk and T2D [71], and although
ABCA1 has not been associated with VAT/SAT ratio, it
was recently identified as a novel locus associated with
body fat distribution with a stronger effect in women
[22], and BMI was found to be positively associated with
VAT/SAT ratio in premenopausal women from the GEA
study bearing the ABCA1/R230C [21] .
ABCA1 and liver enzymes
ABCA1 has not been previously associated with non-
alcoholic fatty liver disease, AST or ALT levels, and no
gene-diet interactions affecting transaminases were ob-
served in the present study. Interestingly, very significant
interactions were observed affecting GGT and ALP
serum levels, showing the same unfavorable pattern in
premenopausal women bearing the R230C variant with
higher dietary carbohydrate and lower dietary fat per-
centages. In clinical practice, serum GGT has been
confirmed to be involved in cardiovascular disease
mechanisms, and several studies have reported an inde-
pendent association of higher GGT levels with metabolic
syndrome, carotid atherosclerosis and cardiovascular
disease [72–75]. On the other hand, increased GGT and
ALP levels are also indicators of liver or biliary tract dis-
eases. ABCA1 is expressed in gallbladder and plays a
role in cholesterol concentrations in bile [76, 77], and
thus higher ALP and GGT levels observed in premeno-
pausal women bearing ABCA1/R230C and consuming
high carbohydrates might be related to a higher risk of
cholestasis or cholelithiasis. Once again, although
ABCA1 has not been reported as a gene associated with
cholelithiasis [78], it might be involved in the pathogen-
esis of the disease in premenopausal women with certain
dietary patterns. Future clinical studies are necessary to
prove whether the interactions here observed are in fact
related to gallbladder disease.
Study limitations
Because this is a cross-sectional design, we cannot infer
causality from the results. The sample size is relatively
small to identify gene-diet interactions, and statistical
power is low, particularly to identify interactions affect-
ing HOMA-IR. Further studies are needed to confirm
Jacobo-Albavera et al. Nutrition & Metabolism  (2015) 12:45 Page 8 of 11
these interactions. One of the main limitations is that
carbohydrate and fat percentage were estimated from a
validated food frequency questionnaire (FFQ). Dietary
intake is difficult to measure, and although doubts of the
accuracy of FFQs have been raised, they are still widely
used as the primary dietary assessment tool in epidemio-
logical studies [79]. The interactions found based on our
FFQ that has been previously validated in the Mexican
population can be used to design more controlled and
accurate dietary intervention studies. Finally, meno-
pausal status was determined by interrogation, and
estrogen levels were not measured.
Conclusion
To our knowledge, this is the first study reporting a
gender-specific interaction between ABCA1/R230C vari-
ant and dietary carbohydrate and fat percentages affect-
ing VAT/SAT ratio, GGT, ALP and adiponectin levels
and HOMA index. Our study also replicated previously
reported ABCA1-diet interaction affecting HDL-C levels
in Mexican premenopausal women observed in an inde-
pendent study. Our results show how gene-environment
interactions may help further understand how certain
gene variants confer metabolic risk, and may provide
information useful to design diet intervention studies.
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